Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key Metrics

Core Insights - DexCom reported revenue of $1.16 billion for the quarter ended June 2025, reflecting a year-over-year increase of 15.2% and exceeding the Zacks Consensus Estimate of $1.12 billion by 3.06% [1] - The company's EPS for the quarter was $0.48, up from $0.43 in the same quarter last year, surpassing the consensus estimate of $0.45 by 6.67% [1] Revenue Breakdown - Revenue in the United States reached $841 million, exceeding the six-analyst average estimate of $809.7 million, with a year-over-year growth of 14.9% [4] - International revenue was reported at $316.1 million, slightly above the six-analyst average estimate of $311.29 million, marking a year-over-year increase of 16% [4] - Hardware revenue was $39.3 million, surpassing the three-analyst average estimate of $38.99 million, but showing a significant decline of 31.4% year-over-year [4] - Revenue from sensors and other products was $1.12 billion, exceeding the three-analyst average estimate of $1.08 billion, with an 18% increase compared to the previous year [4] Stock Performance - DexCom shares have returned +6.9% over the past month, outperforming the Zacks S&P 500 composite's +3.4% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]